Really? You know that a deal for AXAL won't happen tomorrow? If you notice, most of the immunotherapy clinical biotechs are behaving the same way. The mm's and algos have them all trapped in a tight range. That's because they are short and want to kill any rallies. Watch ZIOP and ADRO daily, and you'll see what I mean.
News 
Market Data 
Discover 
AI
